BioArctic AB (publ) (BRCTF) Financials
BRCTF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 287.8 million | 82.0 million |
| March 31, 2026 | 279.9 million | 50.3 million |
| Dec. 31, 2025 | 279.0 million | 65.9 million |
| Sept. 30, 2025 | 274.3 million | 67.1 million |
BRCTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -17.3 million | ? |
| Dec. 31, 2025 | 34.0 million | ? |
| Sept. 30, 2025 | -4.4 million | ? |
BRCTF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -1.1 million |
| March 31, 2026 | 22.0 million |
| Dec. 31, 2025 | -956382 |
| Sept. 30, 2025 | -3.1 million |
BRCTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 203.2 million | - | 7.5 million |
| March 31, 2026 | 212.5 million | - | 4.3 million |
| Dec. 31, 2025 | 237.3 million | 3.1 million | 4.8 million |
| Sept. 30, 2025 | 199.8 million | 3.4 million | 4.9 million |
BRCTF Shares Outstanding
BRCTF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 14.1 million | - | 6.0 million | - |
| March 31, 2026 | - | 15.8 million | 5.5 million | 2.1 million |
| Dec. 31, 2025 | 33.9 million | 9.2 million | 5.4 million | - |
| Sept. 30, 2025 | - | 1.1 million | 5.3 million | 2.0 million |
BRCTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 25.3 million | 2.2 million |
| March 31, 2026 | 45.7 million | 2.0 million |
| Dec. 31, 2025 | 19.9 million | 1.6 million |
| Sept. 30, 2025 | 14.2 million | 1.3 million |
BRCTF
Price: $33.56
52 week price:
Forward Dividend Yield: 0.65%
Dividend Per Share: 0.22 USD
Earnings Per Share: 0.12 USD
P/E Ratio: 279.71
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 1